The p23 co-chaperone is a succinate-activated COX-2 transcription factor in lung adenocarcinoma tumorigenesis
Science Advances · 30.06.2023 · 9 (26)
DOI: 10.1126/sciadv.ade0387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 30.06.2023. Verfasst von Zhenlong Yu und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, the Second Affiliated Hospital, Dalian Medical University, Dalian 116000, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
P23, historically known as a heat shock protein 90 (HSP90) co-chaperone, exerts some of its critical functions in an HSP90-independent manner, particularly when it translocates into the nucleus. The molecular nature underlying how this HSP90-independent p23 function is achieved remains as a biological mystery. Here, we found that p23 is a previously unidentified transcription factor of COX-2, and its nuclear localization predicts the poor clinical outcomes. Intratumor succinate promotes p23 succinylation at K7, K33, and K79, which drives its nuclear translocation for COX-2 transcription and consequently fascinates tumor growth. We then identified M16 as a potent p23 succinylation inhibitor from 1.6 million compounds through a combined virtual and biological screening. M16 inhibited p23 succinylation and nuclear translocation, attenuated COX-2 transcription in a p23-dependent manner, and markedly suppressed tumor growth. Therefore, our study defines p23 as a succinate-activated transcription factor in tumor progression and provides a rationale for inhibiting p23 succinylation as an anticancer chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, the Second Affiliated Hospital, Dalian Medical University, Dalian 116000, China.
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, China.
- School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
- Neurology Department, Dalian University Affiliated Xinhua Hospital, Dalian 116021, China.
- Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
ORCID-Profile: Zhenlong Yu, Yulin Peng, Jian Gao, Meirong Zhou, Lei Shi, Feng Zhao, Chao Wang, Xiangge Tian, Lei Feng, Xiaokui Huo, Deyu Fang, Xiaochi Ma
Zitieren
APA
Yu, Z., Peng, Y., Gao, J., Zhou, M., Shi, L., Zhao, F., Wang, C., Tian, X., Feng, L., Huo, X., Zhang, B., Liu, M., Fang, D., & Ma, X. (2023). The p23 co-chaperone is a succinate-activated COX-2 transcription factor in lung adenocarcinoma tumorigenesis. Science Advances, 9(26). https://doi.org/10.1126/sciadv.ade0387
Vancouver
Yu Z, Peng Y, Gao J, Zhou M, Shi L, Zhao F, et al. The p23 co-chaperone is a succinate-activated COX-2 transcription factor in lung adenocarcinoma tumorigenesis. Science Advances. 2023;9(26). doi:10.1126/sciadv.ade0387
BibTeX
@article{Yu2023,
author = {Yu, Zhenlong and Peng, Yulin and Gao, Jian and Zhou, Meirong and Shi, Lei and Zhao, Feng and Wang, Chao and Tian, Xiangge and Feng, Lei and Huo, Xiaokui and Zhang, Baojing and Liu, Min and Fang, Deyu and Ma, Xiaochi},
title = {The p23 co-chaperone is a succinate-activated COX-2 transcription factor in lung adenocarcinoma tumorigenesis},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {26},
doi = {10.1126/sciadv.ade0387}
}
EUVIMED